News
Market Overview: The Global Nasal Polyposis Drugs Market is expanding rapidly, owing to advances in biologic medicines, minimally invasive surgical procedures, and personalized medicine approaches.
Mississauga, Ontario Tuesday, May 27, 2025, 16:00 Hrs [IST] ...
AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...
Regeneron and SNY's itepekimab meets the primary endpoint in one COPD trial but misses in another, leaving future plans under review.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi SA (NASDAQ:SNY) on Friday announced results from two Phase 3 trials ...
CRSwNP recurrence after surgery is linked to high eosinophils, GERD, diabetes, and asthma. A new model accurately predicts ...
Real Housewives Of Cheshire star Leilani Dowding has revealed she is currently in hospital after undergoing planned septal ...
National Institutes of Health grant will fund randomized clinical trial for treatments Timothy Smith, M.D., M.P.H., professor ...
It is commonly believed that mouth taping provides a variety of health benefits. Mouth taping involves placing a piece of skin-safe or porous tape across your lips to encourage nasal breathing while ...
Doctors typically treat nasal polyps with steroids and saline washes. According to the AAAAI, steroids typically reduce the size of the polyps. However, polyps often return, and some people may ...
Mouth taping is all the rage on social media, but a new study suggests it doesn't have health benefits—and can actually be ...
3d
Pharmaceutical Technology on MSNGSK makes new drug submission for depemokimab in CanadaGSK has made a new drug submission (NDS) to Health Canada for the monoclonal antibody, depemokimab, targeting two specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results